Consun Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 6/6
Consun Pharmaceutical Group has a total shareholder equity of CN¥3.9B and total debt of CN¥503.4M, which brings its debt-to-equity ratio to 12.8%. Its total assets and total liabilities are CN¥5.5B and CN¥1.6B respectively. Consun Pharmaceutical Group's EBIT is CN¥825.9M making its interest coverage ratio -17.3. It has cash and short-term investments of CN¥3.6B.
Key information
12.8%
Debt to equity ratio
CN¥503.42m
Debt
Interest coverage ratio | -17.3x |
Cash | CN¥3.58b |
Equity | CN¥3.92b |
Total liabilities | CN¥1.59b |
Total assets | CN¥5.51b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: C1P's short term assets (CN¥4.3B) exceed its short term liabilities (CN¥1.5B).
Long Term Liabilities: C1P's short term assets (CN¥4.3B) exceed its long term liabilities (CN¥94.3M).
Debt to Equity History and Analysis
Debt Level: C1P has more cash than its total debt.
Reducing Debt: C1P's debt to equity ratio has reduced from 15.7% to 12.8% over the past 5 years.
Debt Coverage: C1P's debt is well covered by operating cash flow (162.7%).
Interest Coverage: C1P earns more interest than it pays, so coverage of interest payments is not a concern.